| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.9M | — | -62.5% |
| R&D Expense | $454K | — | +3.7% |
| SG&A Expense | $19.4M | — | -11.6% |
| Operating Income | -$18.5M | — | -39.6% |
| Pre-tax Income | -$18.8M | — | -41.5% |
| Income Tax | $45K | — | -81.6% |
| Net Income | -$18.9M | — | -39.3% |
| EPS (Basic) | -$2.93 | — | -1992.9% |
| EPS (Diluted) | -$2.93 | — | -1992.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $33.7M | +229.6% | -3.7% |
| Short-term Investments | $37.9M | -28.8% | -27.6% |
| Accounts Receivable | $61.5M | -48.8% | -7.2% |
| Inventory | $23.0M | -4.6% | -41.6% |
| Current Assets | $166.9M | -23.0% | -21.9% |
| Total Assets | $211.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.6M | — | +168.3% |
| Investing Cash Flow | $15.1M | — | +614.8% |
| Financing Cash Flow | -$189K | — | -70.3% |
| -26.2% |
| Current Liabilities | $91.6M | -28.2% | -28.9% |
| Long-term Debt | $39.2M | +0.3% | +0.8% |
| Total Liabilities | $135.7M | -21.6% | -23.7% |
| Stockholders' Equity | $75.6M | -19.5% | -30.3% |